AstraZeneca PLC (ETR:ZEG)
146.55
-2.15 (-1.45%)
Oct 10, 2025, 5:35 PM CET
AstraZeneca Employees
AstraZeneca had 94,300 employees as of December 31, 2024. The number of employees increased by 4,400 or 4.89% compared to the previous year.
Employees
94,300
Change (1Y)
4,400
Growth (1Y)
4.89%
Revenue / Employee
€510,187
Profits / Employee
€74,901
Market Cap
227.76B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 94,300 | 4,400 | 4.89% |
Dec 31, 2023 | 89,900 | 6,400 | 7.66% |
Dec 31, 2022 | 83,500 | 400 | 0.48% |
Dec 31, 2021 | 83,100 | 7,000 | 9.20% |
Dec 31, 2020 | 76,100 | 5,500 | 7.79% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 91,864 |
Fresenius SE & Co. KGaA | 176,486 |
Fresenius Medical Care AG | 111,513 |
Sartorius Aktiengesellschaft | 13,528 |
Fielmann Group AG | 24,363 |
Carl Zeiss Meditec AG | 5,730 |
AstraZeneca News
- 2 days ago - AstraZeneca To Invest $4.5 Bln In Virginia Facility, Create 3,600 Jobs - Nasdaq
- 2 days ago - AstraZeneca (AZN) Boosts U.S. Investment with $4.5B Virginia Facility - GuruFocus
- 2 days ago - AstraZeneca (AZN) Invests $4.5B in New Virginia Facility to Boost Medicine Production - GuruFocus
- 2 days ago - Turbine Partners With AstraZeneca To Accelerate AI-Driven ADC Discovery - Nasdaq
- 2 days ago - AstraZeneca eyes $500M additional investment in new Virginia plant - Seeking Alpha
- 2 days ago - AstraZeneca breaks ground at $4.5 billion Virginia plant as drugmakers court Trump - Reuters
- 2 days ago - AstraZeneca plans to increase investment and scope of its Virginia manufacturing facility to $4.5 billion, creating 3,600 new jobs - Business Wire
- 2 days ago - A Look Into AstraZeneca Inc's Price Over Earnings - Benzinga